97 results
Page 3 of 5
8-K
EX-99.1
3w8wt cgm
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
3kb0 p0dput3k
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
yk9t fdhwz8w
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K/A
EX-99.1
xqjalm0e
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
076a9 8qe3sf5gag6t
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
CORRESP
nmultonl63tlip 6ckw
18 Oct 18
Correspondence with SEC
12:00am
8-K
82u4nsrfjm54z6pbmvy
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
37wxas966z1cvdh
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am